These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6485796)

  • 21. Characterization of pleural effusions by flow-cytometric DNA analysis.
    Høstmark J; Vigander T; Skaarland E
    Eur J Respir Dis; 1985 May; 66(5):315-9. PubMed ID: 4018184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cytological exam of the pleural fluid in the diagnosis of neoplastic pleuritis. Cases contribution].
    Vignale L; Galli G; Rossi PC; Parentini GC
    Minerva Med; 1990 Jun; 81(6):455-9. PubMed ID: 2359501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biochemical and cytologic characteristics of pleural effusions secondary to pulmonary embolism.
    Romero Candeira S; Hernández Blasco L; Soler MJ; Muñoz A; Aranda I
    Chest; 2002 Feb; 121(2):465-9. PubMed ID: 11834658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Routine DNA cytometry of benign and malignant pleural effusions by means of the remote quantitation server Euroquant: a prospective study.
    Kayser K; Blum S; Beyer M; Haroske G; Kunze KD; Meyer W
    J Clin Pathol; 2000 Oct; 53(10):760-4. PubMed ID: 11064669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of immunocytochemical and histochemical stainings in the distinction between reactive mesothelial cells and adenocarcinoma cells in body effusions.
    Chen CJ; Chang SC; Tseng HH
    Zhonghua Yi Xue Za Zhi (Taipei); 1994 Sep; 54(3):149-55. PubMed ID: 7954054
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Living cytology: A new diagnostic technique for malignant pleural effusions.
    Monif GR; Stewart BN; Block AJ
    Chest; 1976 May; 69(5):626-9. PubMed ID: 1269270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radioimmunometric demonstration of immunoglobulin G on cancer cells derived from malignant pleural effusions.
    Górny MK; Micksche M; Wolf A
    Oncology; 1982; 39(1):6-12. PubMed ID: 7036028
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Infection of mesothelial cells with human herpes virus 8 in human immunodeficiency virus-infected patients with Kaposi's sarcoma, Castleman's disease, and recurrent pleural effusions.
    Bryant-Greenwood P; Sorbara L; Filie AC; Little R; Yarchoan R; Wilson W; Raffeld M; Abati A
    Mod Pathol; 2003 Feb; 16(2):145-53. PubMed ID: 12591967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemical panel for distinguishing between carcinoma and reactive mesothelial cells in serious effusions.
    Lee JS; Nam JH; Lee MC; Park CS; Juhng SW
    Acta Cytol; 1996; 40(4):631-6. PubMed ID: 8693877
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor-associated lympho-monocytes from neoplastic effusions are immunologically defective in comparison with patient autologous PBMCs but are capable of releasing high amounts of various cytokines.
    Mantovani G; Macciò A; Pisano M; Versace R; Lai P; Esu S; Massa E; Ghiani M; Dessì D; Melis GB; Del Giacco GS
    Int J Cancer; 1997 May; 71(5):724-31. PubMed ID: 9180137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiparameter flow cytometric DNA analysis of effusions: a prospective study of 36 cases compared with routine cytology and immunohistochemistry.
    Joseph MG; Banerjee D; Harris P; Gibson S; McFadden RG
    Mod Pathol; 1995 Aug; 8(6):686-93. PubMed ID: 8532707
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measurement of DNA content and of tritiated thymidine and bromodeoxyuridine incorporation by the same cells.
    Lin P; Allison DC
    J Histochem Cytochem; 1993 Sep; 41(9):1435-9. PubMed ID: 8354883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA flow cytometry of pleural effusions. Comparison with pathology for the diagnosis of malignancy.
    Evans DA; Thornthwaite JT; Ng AB; Sugarbaker EV
    Anal Quant Cytol; 1983 Mar; 5(1):19-27. PubMed ID: 6846965
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical significance of pleural effusion mesothelin in malignant pleural mesothelioma.
    Yamada S; Tabata C; Tabata R; Fukuoka K; Nakano T
    Clin Chem Lab Med; 2011 Oct; 49(10):1721-6. PubMed ID: 21692685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Numerous mesothelial cells in tuberculous pleural effusions.
    Lau KY
    Chest; 1989 Aug; 96(2):438-9. PubMed ID: 2752834
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA analysis of malignant effusions. Comparison with cytologic diagnosis and carcinoembryonic antigen content.
    Pinto MM
    Anal Quant Cytol Histol; 1992 Jun; 14(3):222-6. PubMed ID: 1418272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fc receptors in the differentiation of mesothelial cells from malignant cells in effusions.
    Chandra M; Nayar M
    Acta Cytol; 1990; 34(4):582-3. PubMed ID: 2375229
    [No Abstract]   [Full Text] [Related]  

  • 38. Tumor type and single-cell/mesothelial-like cell pattern of breast carcinoma metastases in pleural and peritoneal effusions.
    Antic T; Gong Y; Sneige N
    Diagn Cytopathol; 2012 Apr; 40(4):311-5. PubMed ID: 22431319
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interphase nucleolar organizer regions in the evaluation of serosal cavity effusions.
    Carrillo R; Sneige N; el-Naggar AK
    Acta Cytol; 1994; 38(3):367-72. PubMed ID: 8191825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigation of volatile organic metabolites in lung cancer pleural effusions by solid-phase microextraction and gas chromatography/mass spectrometry.
    Liu H; Wang H; Li C; Wang L; Pan Z; Wang L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jan; 945-946():53-9. PubMed ID: 24321761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.